Fenoterol Hydrobromide

氢溴酸非诺特罗

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameFenoterol Hydrobromide
Drug Alias Name非诺特罗氢溴酸盐fenoterolumfenoterolBerotecDosberotec +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsHeart FailurePulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1971/01/01
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsHeart Failure

Other Information

ATC CodeG02CA03R03AC04R03CC04